A Study to Identify and Characterize LAL-D Patients in High-risk Populations

Clinical trial NCT02345421 · TERMINATED

Trial details

NCT number: NCT02345421
Sponsor: Alexion Pharmaceuticals, Inc.
Status: TERMINATED
Study type: OBSERVATIONAL

Lysosomal Acid Lipase Deficiency

Start date: 2014-12-01
Primary completion: 2015-09-01
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.